Brief: Lineage Cell Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
10/03/2022 21:20
March 10 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL
YEAR
2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CASH AND CASH EQUIVALENTS OF APPROXIMATELY $83 MILLION AS
OF
JANUARY 31, 2022
* QTRLY LOSS PER SHARE $0.17
* Q4 EARNINGS PER SHARE VIEW $-0.05 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw6mvHfYa
Further company coverage: LCTX.A
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million